Actively Recruiting
Comparison of Safety and Efficacy of Detaenial Sigmoid Neobladder and Ileal Neobladder
Led by Zhujiang Hospital · Updated on 2024-12-04
96
Participants Needed
1
Research Sites
386 weeks
Total Duration
On this page
Sponsors
Z
Zhujiang Hospital
Lead Sponsor
S
Sun Yat-Sen University Cancer Center
Collaborating Sponsor
AI-Summary
What this Trial Is About
Bladder cancer is a common malignant tumor of the urinary system, radical resection plus urinary diversion is the first choice of treatment for muscle invasive bladder cancer. Urinary diversion of surgical options related to patient' survival and quality of life. In 1988, Hautmann firstly reported an orthotopic urinary diversion method: Hautmann neobladder. As the urine can be controlled from the original urethra, the patient's quality of life has been greatly improved, so the new bladder surgery gradually accepted and welcomed by urologists and patients. However, in order to achieve low-pressure and large-volume storage capacity of the urine reservoir, the 40-70cm long interception of terminal ileum need to be detubularized. Only after split, folded, re-stitched and a series of treatment, the intestinal can be used. Such complicated procedures make so many urologists give it up. In addition, the interception of the long ileum may lead to reduced absorption of vitamin B12 which caused anemia, metabolic acidosis, intestinal dysfunction. Not only that, as time goes by, this kind of neobladder will be unlimited expansion and resulting in a serious increase in residual urine volume, hydronephrosis, or even the occurrence of neobladder spontaneous rupture. In 2000, professor Chunxiao Liu invented "detaenial sigmoid neobladder", this surgical method overset the traditional intestinal detubularization approach, which detached the serosal layer with smooth muscle from the bowel without split it. This kind of neobladder is easier to construct and have less impact on intestinal function. So far, it has been implemented for more than 600 cases in Zhujiang hospital, the age of patients range from 9 months (bladder rhabdomyosarcoma) to 84 years old. So far as now, no multicenter prospective clinical study on orthotopic urinary diversion has been performed worldwide, neither the head-to-head studies on detaenial sigmoid neobladder and ileal neobladder. Our project is going to perform a multicenter randomized controlled trial for these two neobladder methods and look forward to assess the safety and efficacy of these two procedures which provide an objective basis for the patients undergoing orthotopic urinary diversion in the future.
CONDITIONS
Official Title
Comparison of Safety and Efficacy of Detaenial Sigmoid Neobladder and Ileal Neobladder
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Bladder carcinoma in situ, including CIS and T1G3 tumor, muscle invasive bladder cancer (T2/T3N0-1M0)
- Recurrent bladder cancer
- Other conditions approved by a urologist for new bladder surgery
- Previous intravesical chemotherapy, intra-arterial infusion chemotherapy, or systemic chemotherapy
- Voluntarily signed informed consent
You will not qualify if you...
- Preoperative serum creatinine more than 2.26 mg/dl (or 200 bcmol/L)
- Cancer invasion of urethra confirmed by pathology
- Patients without bladder cancer who underwent neobladder
- History of other malignant tumors within five years
- Chronic inflammation of ileum or sigmoid, such as ulcerative colitis or intestinal tuberculosis
- Other conditions approved by a urologist as unsuitable for new bladder surgery
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Zhujiang Hospital
Guangzhou, Guangdong, China, 510282
Actively Recruiting
Research Team
A
Abai Xu, doctor
CONTACT
P
Peng Xu, doctor
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here